Immunotherapy: can the hype deliver?
Dr Ignacio Melero will be chairing the Immunotherapy in Cancer track at this year’s European Cancer Congress (and is also researcher/clinician at the University Clinic of Navarra and the Centre of Applied Medical Research, Pamplona, Spain). According to Melero, “most of the oncologists and haematologists perceive immunotherapy as probably the main area to progress and to achieve better therapeutic efficacy, at the very least for the next five years”.
The growing interest around immunotherapy means that it is sure to be one of the main draws at this year’s congress, and Ignacio believes that the atmosphere which has left “even the most sceptical about immunotherapy really falling in love with the field” will leave plenty of others head over heels in Vienna.